Cargando…
Cutaneous presentation of cryptococcal infection with subclinical central nervous system involvement secondary to fingolimod therapy
Fingolimod is a multiple sclerosis disease-modifying therapy which sequestrates lymphocytes in the lymph nodes, thereby reducing peripheral blood lymphocytes. Cryptococcal infection is an important adverse effect which should be recognised. We report a case of cutaneous and central nervous system in...
Autores principales: | Chey, Shin Yee, O’Sullivan, Niamh-Anna, Beer, Trevor, Leong, Wai K, Kermode, Allan G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478555/ https://www.ncbi.nlm.nih.gov/pubmed/37674981 http://dx.doi.org/10.1177/20552173231197132 |
Ejemplares similares
-
Central Nervous System Demyelination Related to Tumour Necrosis Factor Alpha Inhibitor
por: Chey, Shin Yee, et al.
Publicado: (2022) -
Primary cutaneous cryptococcal infection due to fingolimod – Induced lymphopenia with literature review
por: Patil, Sachin M., et al.
Publicado: (2020) -
Cryptococcal Meningitis Reported With Fingolimod Treatment: Case Series
por: Del Poeta, Maurizio, et al.
Publicado: (2022) -
Gelatinous pseudocysts in cryptococcal infection of the central nervous system
por: Ding, Joy Zhuo, et al.
Publicado: (2021) -
Pregnancy outcome following exposure to ocrelizumab in multiple sclerosis
por: Chey, Shin Yee, et al.
Publicado: (2022)